Novartis Investigative Site

Christchurch, Christchurch 8001

0 studies enrolling now · 2 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Breast Cancer

Studies at this site

• Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease — Running, not enrolling
• Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole — Completed